Author:
Alizadeh Yousef,Akbari Mitra,Soltanipour Soheil,Moghadam Reza Soltani,Medghalchi Abdolreza,Dourandeesh Maryam,Alizadeh Halleh
Subject
Pharmaceutical Science,Pharmacy,Education
Reference41 articles.
1. 1. Nicolò M, Desideri LF, Vagge A, Traverso CE. Current Pharmacological Treatment Options for Central Serous Chorioretinopathy: A Review. Pharmaceuticals (Basel) 2020;13(10):264.
2. 2. Mishra A, Baranwal V, Aggarwal S, Shankar S, Parihar JS, Ahluwalia T. The fluorescein angiographic characteristics of acute central serous chorioretinopathy among Indians vis-a-vis the other Asian and Western populations. J Clin Ophthalmol Res. 2018;6(1):20-3.
3. 3. Sartini F, Figus M, Nardi M, Casini G, Posarelli C. Non-resolving, recurrent and chronic central serous chorioretinopathy: available treatment options. Eye (Lond) 2019;33(7):1035-43.
4. 4. Goldhagen BE, Goldhardt R. Diagnosed a Patient with Central Serous Chorioretinopathy? Now What? Management of Central Serous Chorioretinopathy. Curr Ophthalmol Rep. 2017;5(2):141-8.
5. 5. Fusi-Rubiano W, Saedon H, Patel V, Yang Y. Oral medications for central serous chorioretinopathy: a literature review. Eye (Lond). 2020;34(5):809-24.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献